Treatment of acute promyelocytic leukemia with arsenic trioxide.
Tamm
I
I
Paternostro
G
G
Zapata
J M
JM
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology* / Q000627:therapeutic use; D001853:Bone Marrow / Q000201:enzymology*; D020169:Caspases / Q000378:metabolism*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000473:pathology*; D010087:Oxides / Q000494:pharmacology* / Q000627:therapeutic use; D012074:Remission Induction
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D020169:Caspases; D000077237:Arsenic Trioxide